About the Journal

 

Instructions to authors

(Updated: 2022/09/29)

Scope and policy

 

1 SCOPE

The Journal of Applied Oral Science (JAOS) it is committed to publishing the scientific and technological advances achieved by dental, and speech-language pathology and audiology communities, according to the quality indicators,  with the objective of assuring its acceptability within its knowledge fields. The primary goal of JAOS is to publish the outcomes of original research/clinical investigations in the field of Oral Sciences, with emphasis in dentistry, speech-language pathology and audiology, and related areas.

Submissions of case reports (including case series and clinical protocols) and short communication  are no longer accepted by JAOS and review manuscripts (including systematic reviews) can only be submitted under the editor's invitation.

This Journal adopts Creative Commons license CC BY:

"This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. This is the most accommodating of licenses offered. Recommended for maximum dissemination and use of licensed materials."

1.1 Publication fee

There is no fee for authors to submit to JAOS nor Article Processing Charge (APC).

2 GENERAL GUIDELINES

2.1 Originality

The papers sent for publication must be original and the simultaneous submission to another journal, either national or international, is not allowed. JAOS shall retain the copyright of all papers published, including translations; future reproduction as a transcription is allowed, provided the source is properly mentioned.

2.2 Acceptance of preprints

The JAOS is open for preprint submissions. A preprint is defined as a manuscript, ready for submission that is deposited on trusted preprint servers before or in parallel to the submission to a journal. Only submissions of papers previously deposited on these servers will be accepted, which will be duly evaluated for their recognition and quality by JAOS.

In case of acceptance and publication of the article in JAOS, the authors must update the registration status on the preprint server, informing the complete reference of the publication in the journal.

2.3 Research data and data repository

Research data corresponds to any information that has been observed, collected, generated, or created to validate original research findings. This includes raw data, processed data, audio, video, code, software, algorithms, protocols, and methods. While usually digital, research data also includes non-digital formats such as laboratory notebooks and diaries.

Authors must ensure that confidential data must not be shared to preserve the ethicality, legality, and privacy when appropriate, otherwise, consent to release data must be provided by the involved participants. Research data that are not required to verify the results reported in articles are not covered by this policy.

The preferred mechanism for sharing research data is via data repository, which consists in a relevant tool for the authors/contributors to archive and share organized original and processed research data with or without supplemental material. We encourage the use of good practice according to the Open Science to assure safety and transparency.

Among the JAOS recommended data repositories, the SciELO Data repository is included. It is a tax-free and open system, which enables the contributors to deposit research data in association to a specific manuscript. Using SciELO Data, authors should present the data ONLY after acceptance of the manuscript. JAOS follows a Research Data Policy Type 3 and adopts Level 1 Curation.

Data repositories to deposit your research data are available at https://repositoryfinder.datacite.org/. To ensure the quality and recognition of the data generated, JAOS recommends and follows the FAIR principles (Findable, Accessible, Interoperable, and Reusable).

To make these data available in accordance with SciELO’s policies, authors must fill in the Open Science Compliance form.

Embargoes on data sharing are permitted. When publishing a dataset, the author may choose to defer the date at which the data becomes available. This means that the description and files of that dataset are not publicly available until the embargo date is reached. Meanwhile, other information about the dataset, such as the contributors, title, citation and associated articles, becomes available immediately prior to the embargo.

Sharing research data as supplementary information files is discouraged. For some types of data, research data sharing via Supplementary Materials is not allowed. Authors are encouraged to ensure that their datasets are either deposited in publicly available repositories presented in the main manuscript.

JAOS encourages authors to cite any publicly available research data in their reference list. References to datasets (data citations) must include a persistent identifier (such as a DOI). Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow JAOS style.

Example:

Mahardawi B. The role of hemostatic agents following dental extractions: a systematic review and meta-analysis [dataset]. 2022 Mar 14 [cited 2022 Apr 22]. In: Dryad [Internet]. doi: 10.5061/dryad.59zw3r297. Available from: https://doi.org/10.5061/dryad.59zw3r297

JAOS encourages research data to be made available under open licenses that allow free reuse and recommends the adoption of the CC BY 4.0 License (Creative Commons Attribution 4.0 International) which authorizes the sharing, using, and adaptation of research data provided that credit to the authors is ensured, but the author can decide which Creative Commons License is best suited to the type of data deposited.

JAOS requires authors to include a Data Availability Statement to any article that report results derived from research data. The provision of a Data Availability Statement will be verified as a condition of publication and should present information on where the data supporting the results reported in the article can be found including, when applicable, hyperlinks to publicly archived datasets analyzed or generated during the study. When research data are not publicly available, this must be stated in the manuscript along with any conditions for accessing the data. Data Availability Statements commonly take one of the following forms:

  •   Data available in a publicly accessible repository

The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [DOI – PERSISTENT WEB LINK TO DATASETS].

  •  Data available on request due to restrictions, e.g., privacy or ethical

The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

  •   Data sharing not applicable

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

  •   Data is contained within the article

 All data generated or analyzed during this study are included in this published article [and its supplementary information files].

  •   3rd Party Data

The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name]

Questions about complying with this policy should be sent to jaos@usp.br

2.4 JAOS will only accept submissions of manuscripts written in English. The English language should also be adopted in all documents during the procedures involving the articles. The content of the texts, quotations, and references of the papers submitted and published are of the sole responsibility of the authors, not necessarily reflecting the opinion of JAOS’s Editor-in-Chief or Editorial Board.

2.5 JAOS has the right to submit all manuscripts to the Editorial Board, which is fully authorized to determine the appropriateness of their content to peer review (otherwise, manuscripts will receive an Immediate Rejection decision), and the subsequent decision regarding acceptance/rejection, or return them to the authors with suggestions and modifications to the text and/or for them to adapt it to the editorial standards of the journal. In this case, the manuscript will be reevaluated by the Editor-in-Chief and the Editorial Board.

2.6 The dates of receipt of the original article was received and accepted will appear when published in the JAOS.

2.7 JAOS is published exclusively in electronic format.

3 EVALUATION CRITERIA

3.1 Pre-evaluation: manuscripts will be appreciated by Editors-in-Chief and Associate Editors for their adequacy to the Journal’s scope, priority and potential publication and citation impact, degree of novelty and methodology. Manuscripts that do not meet the set of these requirements at this step will be rejected and returned to authors, while the manuscripts considered adequate will follow the regular peer review process.

3.2 Technical review: manuscripts approved in the pre-evaluation stage will be then evaluated for their compliance to the publication norms and presence of mandatory documents required for submission to JAOS. Manuscripts not in accordance with instructions will be returned to authors for adjustments before being reviewed by Associate Editors and referees.

3.3 Merit and content evaluation: papers approved by Associate Editors will be evaluated in their scientific merit and methods by at least two ad hoc referees from different institutions of that of the authors, besides the Editor-in-Chief.

3.3.1 As part of the evaluation process, all manuscripts, in all rounds of the review, will be submitted to analysis by a plagiarism software.

3.3.2 The Editor-in-Chief will decide on manuscript acceptance. When revision of the original is required, the manuscript will be returned to the corresponding author for modification. A revised version with modifications will be re-submitted by the authors, and that will be re-evaluated by the Editor-in-Chief, Editorial Board, and ad hoc referees, if necessary.

3.4 After approval of the scientific merit, manuscripts will pass through a final review performed by a professional assigned by JAOS. If manuscripts are still considered inadequate, they will be returned to authors for revision.

3.5 Authors and referees will be kept anonymous during the review process.

4 GALLEY PROOFS

4.1 Galley proofs of each article will be sent to the corresponding author by electronic mail in PDF format for final approval.

4.2 If necessary, authors will have 48 hours to make corrections and return the revised article.

4.3 The only corrections accepted will be minor spelling corrections and the verification of figures. Major corrections will cause the manuscript to undergo a new revision by referees and delay its publication.

4.4 If the galley proof is not returned in 48 hours, the Editor-in-Chief will consider it the unchanged final version.

4.5 Inclusion of new authors is not allowed at this stage of the publication process.

4.6 It is the sole responsibility of the authors to verify the proper use of their citation names and affiliation in the manuscript.

 

 

Form and preparation of manuscripts

 

1 PRESENTATION OF THE MANUSCRIPT

1.1 Structure of the manuscript

1.1.1 Cover page must be submitted as a supplementary file and should contain only:

  •  Title of the manuscript in English.
  •  Names of the authors in direct order with their respective affiliations in English. Affiliations must be written in Portuguese for Brazilian authors, in Spanish for Latin-American authors, and in English for the other nationalities.
  •  Full address of the corresponding author, to whom all correspondence should be addressed, including phone number as well as e-mail address.
  •  Information about the deposit of the manuscript on a preprints server, when applicable, indicating the access address and DOI number, if required (attach the Open Science Compliance form). Citation and referencing of the research data specifying the repository and the DOI number (attach the Open Science Compliance form).
  •  Mandatory note stating whether the manuscript is derived from any dissertations or theses and their respective access address when available.

1.1.2 Text

  •  The paper must be previously translated into English language or proofread by a copyediting company or professional.
    Authors with English as native language must submit as supplementary file a signed letter taking responsibility for the quality of the English language and editing of the text.
  •  Title of the manuscript in English.
  •  Abstract structured in a sole paragraph: should comprise at most 300 words, highlighting a little introduction, objective, methodology, results, and conclusions.
  •  Keywords: words or expressions that identify the contents of the manuscript. The authors must check both MeSH and DeCS. Authors must use periods to separate the keywords, which must have the first letter of the first word in capital letters. Ex: Dental implants. Fixed prosthesis. Photoelasticity. Passive fit.
  •  Graphical abstract: A graphical abstract is a visual format of the manuscript to summarize the essential findings of the study. It helps to promote easy and concise information that can be quickly embedded by the readers and helps to be shared, including in social medias. Therefore, JAOS encourages this submission. An original figure that states clearly the sequence described in the manuscript needs to be designed (JPEG, minimum of 300 dpi and 1328 x 531 pixels (w x h)) and submitted as a separate file as supplementary material.

    Examples: https://www.instagram.com/p/CL44dlbF-wu/
    https://www.instagram.com/p/CVh4M9aFsGw/
    https://www.instagram.com/p/CHhyixyFkag/
     
  •  Introduction: summary of the rationale and proposal of the study including only relevant references. It should clearly state the hypothesis of the study.
  •  Methodology: the material and the methods are presented with enough detail to allow confirmation of the findings. Include the city, state, and country of all manufacturers right after the first appearance of the products, reagents or equipment etc. Published methods should be referred to and briefly discussed, except if modifications were made. Indicate the statistical methods employed, if applicable. Please refer to item 3 for ethical principals and registration of clinical trials.
  •  Results: must be presented in a logical sequence in the text, tables, and illustrations. Data contained in tables and illustrations should not be repeated in the text, and only important findings should be highlighted. Please, use the fewest number tables and figures as possible.
  •  Discussion: this section should emphasize the new and important aspects of the study, discussing them with prior investigations. Any data or information mentioned in the introduction or results should not be repeated.The authors should stress the implications of their findings, as well as their limitations.
  •  Conclusion(s): Provide short conclusions that can be taken from the research. Go further than reaffirming the results, establishing relevant conclusions to the objectives based on the data. In most cases, the conclusions are only true for the study population.
  •  Acknowledgments (when appropriate): Acknowledge those who have contributed (person, laboratory, section, etc.) to the work. Specify sponsors, grants, scholarships and fellowships with respective names and identification numbers.
  •  References (please refer to item 2.3)

2 TECHNICAL NORMALIZATION

The text body of the manuscript should be typed as follows: 1.5 spacing in 11 pt Arial font, with 3-cm margins at each side, on an A4 page, adding up, to at most, 12 pages, thus excluding figures, tables, figure caption, and references.

2.1 Illustrations and Tables

2.1.1 The illustrations (photographs, graphs, drawings, charts, etc.), regarded as figures, should be limited to the least amount possible and should be uploaded in separate files, consecutively numbered with Arabic numbers according to the order they appear in the text.

2.1.2 All illustrations must be inserted in the body of the Word file but uploaded separately as individual files during the submission of the article. Photographs should be uploaded in .jpg format with at least 300 dpi and 10 cm width.

2.1.3 The tables should be logically arranged, consecutively numbered with Arabic numbers and the captions shall be placed above the tables. Tables should be open in the right and left laterals, removing any internal horizontal or vertical lines, as well as any colors or shades. Tables must be uploaded in .xls format.

2.1.4 The corresponding figure and table captions should be clear, concise and typed at the end of the manuscript as a separate list preceded by the corresponding number.

2.1.5 Footnotes for illustrations and tables should be indicated by asterisks and restricted to the least amount possible.

2.2 Citation of the Authors

Citation of the authors in the text may be performed in two manners:

1) Just numeric: ...and interfere with the bacterial system and tissue system.3,4,7-10 

References must be cited in a numeric ascending order within the paragraph.

2) or alphanumeric

  •  one author - Gatewood31 (2012)
  •  two authors - Cotti and Mercuro19 (2016)
  •  three authors - Azar, Safi, Nikaein27 (2012)
  •  more than three authors - Gealh, et al.28 (2014)

2.3 References

The references must follow the "Uniform requirements for manuscripts submitted to Biomedical Journals - Vancouver" available at: http://www.nlm.nih.gov/bsd/uniform_requirements.html.

2.3.1 All references must be cited in the text. They should be numbered consecutively in the order in which they are first mentioned in the text. Abbreviations of the titles of the journals cited should follow MEDLINE.

2.3.2 Personal communications and unpublished data with no publication date must not be included in the reference list.

2.3.3 Theses, dissertations, monographs, and abstracts will not be accepted as references.

2.3.4 Avoid referencing articles published in languages other than English (if included, limit them to a maximum of 3). The English translation of the title must appear between brackets with the original title at the end of the reference.

2.3.5 The names of all authors should be cited, if up to 6 authors; in case there are more authors, the 6 first authors should be cited, followed by the expression ", et al.", which must be followed by period and should not be written in italics. Ex: Cintra LT, Samuel RO, Azuma MM, Ribeiro CP, Narciso LG, Lima VM, et al.

2.3.6 At most 40 references may be cited.

Examples of references:

Book

Preedy VR, organizator. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015.

Book chapter

Buzalaf CP, Leite AL, Buzalaf MA. Fluoride metabolism. In: Preedy VR, organizator. Fluorine: chemistry, analysis, function and effects. London: Royal Society of Chemistry; 2015. p. 54-72.

Papers published in journals

Conti PC, Bonjardim LR, Stuginski-Barbosa J, Costa YM, Svensson P. Pain complications of oral implants: Is that an issue? J Oral Rehabil. 2021;48(2):195-206. doi: 10.1111/joor.13112.

Papers published in journals in languages other than English

Schubert O, Le V, Probst F. Chancen und Risiken von Zahnimplantaten [Dental implants - opportunities and risks]. MMW Fortschr Med. 2022;164(9):50-2. German. doi: 10.1007/s15006-022-0970-4

Online-only journal article (with electronic identifier)

Peixoto KO, Resende CM, Almeida EO, Almeida-Leite CM, Conti PC, Barbosa GA, et al. Association of sleep quality and psychological aspects with reports of bruxism and TMD in Brazilian dentists during the COVID-19 pandemic. J Appl Oral Sci [Internet]. 2021 [cited 2022 June 20];29:e20201089. Available from: http://dx.doi.org/10.1590/1678-7757-2020-108.

Journal article with DOI

Francese MM, Gonçalves IV, Vertuan M, Souza BM, Magalhães AC. The protective effect of the experimental TiF4 and chitosan toothpaste on erosive tooth wear in vitro. Sci Rep. 2022;12(1):7088. doi: 10.1038/s41598-022-11261-1

Journal article Epub ahead of print/In press/Forthcoming

Pucciarelli MG, Toyoshima GH, Oliveira TM, Neppelenbroek KH, Soares S. Quantifying the facial proportions in edentulous individuals before and after rehabilitation with complete dentures compared with dentate individuals: a 3D stereophotogrammetry study. J Prosthet Dent. Forthcoming 2022. doi: 10.1016/j.prosdent.2022.03.013

Preprint

Weissheimer T, Só MV, Alcalde MP, Cortez JB, Rosa RA, Vivan RR, et al. Evaluation of mechanical properties of coronal flaring nickel-titanium instruments. Research Square rs-49258/v1 [Preprint]. 2020 [cited 2020 Sept 2]. Available from: https://doi.org/10.21203/rs.3.rs-49258/v1

Research data

Mahardawi B. The role of hemostatic agents following dental extractions: a systematic review and meta-analysis [dataset]. 2022 Mar 14 [cited 2022 Apr 22]. In: Dryad [Internet]. doi: 10.5061/dryad.59zw3r297. Available from: https://doi.org/10.5061/dryad.59zw3r297

Papers with more than 6 authors

The first 6 authors are cited, followed by the expression ", et al."

Bergantin BT, Di Leone CC, Cruvinel T, Wang L, Buzalaf MA, Borges AB, et al. S-PRG-based composites erosive wear resistance and the effect on surrounding enamel. Sci Rep. 2022;12(1):833. doi: 10.1038/s41598-021-03745-3

Volume with supplement and/or Special Issue

Ricomini AP Filho, Chávez BA, Giacaman RA, Frazão P, Cury JA. Community interventions and strategies for caries control in Latin American and Caribbean countries. Braz Oral Res. 2021;35(suppl 1):e054. doi: 10.1590/1807-3107bor-2021.vol35.0054

The authors are fully responsible for the correctness of the references.

3 ETHICAL PRINCIPLES AND REGISTRATION OF CLINICAL TRIALS

3.1 Experimental procedures in humans and animals

JAOS reassures the principles incorporated in the Helsinky Declaration and insists that all research involving human beings, in the event of publication in this journal, be conducted in conformity with such principles and others specified in the respective ethics committees of the authors’ institution. In the case of experiments with animals, the same ethical principles must also be followed. When surgical procedures in animals were used, the authors should present, in the Methodology section, evidence that the dose of a proper substance was adequate to produce anesthesia during the entire surgical procedure. All experiments conducted in human or animals must accompany a description, in the Methodology section, that the study was approved by the respective Ethics Committee of authors’ affiliation and provide the number of the protocol approval.

3.1.1 Papers presenting experimental studies in human volunteers or in animals must contain the Ethical Committee approval of the reports as mandatory supplementary file.

3.1.2 Papers describing studies in animals must be submitted with the ARRIVE Checklist as mandatory supplementary file. The ARRIVE Checklist is available at

https://mc04.manuscriptcentral.com/societyimages/jaos-scielo/ARRIVEChecklist.docx

3.1.3 Ethics Committee certificate written in different languages from English, Spanish, and Portuguese must be fully translated into English.

3.2 Clinical Trial Registration involving human subjects

JAOS supports the policies of the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) for the registration of clinical trials. The journal recognizes the importance of such initiatives for the registration and international dissemination of clinical studies with an open access. Therefore, JAOS will publish only the clinical trials that have previously received an identification number validated by the criteria established by the WHO and ICMJE.

Clinical trials are referred as any research study that prospectively or retrospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate health effects and outcomess. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioral treatments, process-of-care changes, preventive care, etc.

3.2.1 Manuscripts presenting interventional clinical trials in human volunteers must be submitted with the following mandatory supplementary files:

Submissions with a registration date after the date of submission of the article to JAOS will not be accepted.

3.2.2 Manuscripts that involve observational clinical trials in human volunteers must be submitted with two mandatory supplemental files:

  •  STROBE checklist.
  •  registration confirmation number of the research in a database that meets the requirements of the WHO and the ICMJE

Submissions with a registration date after the date of submission of the article to JAOS will not be accepted.

3.2.3 Manuscripts that involve surveys with human volunteers must be submitted with two mandatory supplemental files:

  •   CHERRIES checklist.
  •   registration confirmation number of the research in a database that meets the requirements of the WHO and the ICMJE.

Submissions with a registration date after the date of submission of the article to JAOS will not be accepted

3.3 Systematic Reviews

Systematic Reviews SHOULD ONLY BE SUBMITTED AT THE INVITATION OF JAOS. And even in these cases, JAOS will only receive Systematic Reviews of any kind (Traditional, Overviews, Umbrella Reviews, and Scoping Reviews) if they meet the following mandatory requirements:

Submissions with a registration date after the date of submission of the article to JAOS will not be accepted

3.4 The Editor-in-Chief and the Editorial Board reserve the right to refuse manuscripts that show no clear evidence that these principals were followed or in which the methods used were considered inappropriate for experiments in humans or animals.

4 ANY FURTHER QUERIES SHALL BE SOLVED BY THE EDITOR-IN-CHIEF AND EDITORIAL BOARD

 

 

Sending of manuscripts

 

1 MANUSCRIPT SUBMISSION

1.1 Articles must be submitted through the following address https://mc04.manuscriptcentral.com/jaos-scielo

1.2 The original file containing the main manuscript must be submitted without the authors’ identification and affiliations.

1.3 The cover page must be submitted as supplementary file containing the names of the authors, affiliations and correspondence address, citation and reference of the data repository and preprint server used (when appropriate), and the obligatory note for when the manuscript is derived from a dissertation/thesis.

1.4 Figures must be submitted as supplementary files according to the specifications of item 2.1 regarding the form and preparation of manuscripts.

1.5 Tables must be prepared in Excel format and must be submitted as supplementary files.

1.6 Documents of proof – Ethics Committee protocol, ARRIVE ChecklistCONSORT Checklist or SPIRIT Checklist, Clinical trial registration, STROBE ChecklistCHERRIES ChecklistPRISMA Checklist, and PROSPERO Registration must be submitted as mandatory files.

1.7 An English editing certificate (signed by a professional or an editing company) must be submitted as mandatory supplementary file.

1.8 The submission form, signed by ALL authors, must be submitted as a mandatory file.

1.9 The Open Science Compliance Form MUST be submitted as a supplementary file.

1.10 JAOS requires the inclusion of the ORCID registration number of the authors for manuscript submission. All authors must associate the ORCID registration number to their profile on ScholarOne.

 

Information Services

 

The articles published in the Journal of Applied Oral Science are indexed or summarized by:

  •  LILACS: 1993-
  •  Bibliografia Brasileira de Odontologia (BBO): 1993-
  •  Ulrich's: 1993-
  •  Portal de Revistas da USP: 2003-
  •  DOAJ -Directory of Open Access Journals: 2004-
  •  SCOPUS: 2006-
  •  PubMed/Medline: 2006-
  •  PubMed Central: 2006-
  •  Web of Science: 2007-
  •  US Cochrane Centers Master List of Journals: 2007-
  •  Science Citation Index Expanded (SCIE): 2007-
  •  Latindex: 2008-
  •  Sherpa Romeo: 2022-
     
 

 

Intellectual Property

 

All content of the journal, except where identified, is licensed under a Creative Commons Attribution type CC BY.

 

 

Sponsors

 

The publication of this journal is financially supported by:

  •  Programa de Apoio a Publicações Científicas do Ministério da Ciência e Tecnologia e Inovações (MCTI), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and by CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

  •  Bauru School of Dentistry, University of São Paulo (FOB-USP)